摘要
背景:口服药物传播广泛,因为其非侵入性质补充了高度的患者依从性。然而,通过口服途径的药物管理是相当具有挑战性的,因为存在妨碍摄取以及获得血液的生物化学屏障。除此之外,通过胃肠(GI)管道给药的药物的稳定性,溶解性差和生物利用度也很难。迄今为止,已经开发了能及时释放药物但缺乏适当治疗浓度的各种口服制剂。 目的:最近纳米颗粒药物输送系统已经成为优化口服药物输送和最大化治疗效率的突出策略。此外,不同的战略聚合物纳米颗粒被设计用于在细胞外和细胞内水平与胃肠粘膜的相互作用。 方法:本文综述了聚合物和脂质的各种纳米载体,已被广泛研究用于增强不同治疗分子的口服药物递送,并解决了生物相容性和可生物降解的聚合物纳米粒子方法的改进进展。 结论:许多口服纳米颗粒药物递送载体的进展将极大地有助于改善治疗功效,减少不良副作用。不同于其他形式的管理,它将具有更好的患者依从性和舒缓作用。口服药物交付必将在扩大临床表现和应用方面发挥关键作用。
关键词: 口服递送,聚合物纳米粒子,脂质纳米粒子,生物屏障,生物利用度
Current Medicinal Chemistry
Title:Polymeric Biomaterial and Lipid Based Nanoparticles for Oral Drug Delivery
Volume: 24 Issue: 22
关键词: 口服递送,聚合物纳米粒子,脂质纳米粒子,生物屏障,生物利用度
摘要: Background: Oral drug delivery is widespread owing to its non-invasive nature which complements high patient compliance. However, the drug administration via oral route is quite challenging due to the presence of the biochemical barriers which hinders the uptake as well as access to blood stream. Apart from that, stability, poor solubility and bioavailability of administered drug via the gastrointestinal (GI) tract are also exigent. Till now various oral formulations were developed which releases the drug in a timely manner but lacks appropriate therapeutic concentration.
Objective: Recently nanoparticles based drug delivery system has emerged as prominent strategy for optimizing the oral drug delivery and maximizing the treatment efficiency. Besides, different strategic polymeric nanoparticles are engineered for interaction both at extracellular and intracellular levels with gastrointestinal mucosa. Methods: The review article focuses on the polymeric and lipid based various nanocarriers that have been widely studied for the enhanced oral drug delivery of different therapeutic molecules and addresses recent progress of biocompatible and biodegradable polymeric nanoparticles approach for its improvement. Conclusion: The progress of numerous oral nanoparticulate drug delivery vehicles will be immensely helpful to improve therapeutic efficacy with reduced adverse side effects. Unlike other forms of administration, it will have better patient compliance and soothing effect. The oral drug delivery will certainly play a pivotal role soon in expanding the clinical repertoire and applications.Export Options
About this article
Cite this article as:
Polymeric Biomaterial and Lipid Based Nanoparticles for Oral Drug Delivery, Current Medicinal Chemistry 2017; 24 (22) . https://dx.doi.org/10.2174/0929867323666161028160004
DOI https://dx.doi.org/10.2174/0929867323666161028160004 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting Protein Kinase C (PKC) in Physiology and Cancer of the Gastric Cell System
Current Medicinal Chemistry Inhibition of Drug Efflux in Mycobacteria with Phenothiazines and Other Putative Efflux Inhibitors
Recent Patents on Anti-Infective Drug Discovery miR-202 Mediates Metabolic Shift in Lung Cancer Cells via Targeting HK2
Current Signal Transduction Therapy Scalarane Sesterterpenoids
Current Bioactive Compounds Neuropeptide Y Induces Cardiomyocyte Hypertrophy <i>via</i> Attenuating miR-29a-3p in Neonatal Rat Cardiomyocytes
Protein & Peptide Letters Hedgehog Signaling and Urological Cancers
Current Drug Targets Pathogenesis, Experimental Models and Contemporary Pharmacotherapy of Irritable Bowel Syndrome: Story About the Brain-Gut Axis
Current Neuropharmacology Regulatory T Cells and Cancer Therapy: An Old Story with a New Hope
Current Cancer Therapy Reviews Recent Advances in the Synthesis and Application of Bismuth-Containing Heterocyclic Compounds
Current Organic Chemistry Therapeutic Use of Heat Shock Protein 70
Recent Patents on DNA & Gene Sequences Breaking the DNA Damage Response via Serine/Threonine Kinase Inhibitors to Improve Cancer Treatment
Current Medicinal Chemistry Telomerase Modulation in Therapeutic Approach
Current Pharmaceutical Design BUB1B Promotes Proliferation of Prostate Cancer via Transcriptional Regulation of MELK
Anti-Cancer Agents in Medicinal Chemistry Cyclooxygenase-2 Biology
Current Pharmaceutical Design Preoperative Albumin Level Serves as a Predictor for Postoperative Pulmonary Complications Following Elective Laparoscopic Gastrectomy
Current Pharmaceutical Design Crosstalk of Long Non-coding RNAs and EMT: Searching the Missing Pieces of an Incomplete Puzzle for Lung Cancer Therapy
Current Cancer Drug Targets Microaspiration in Intubated Critically Ill Patients: Diagnosis and Prevention
Infectious Disorders - Drug Targets Dysregulated Chemokine Signaling in Cystic Fibrosis Lung Disease: A Potential Therapeutic Target
Current Drug Targets Bioconjugation of Ionophore Antibiotics: A Way to Obtain Hybrids with Potent Biological Activity
Mini-Reviews in Organic Chemistry Cyclodextrin Based Nanosponges: A Multidimensional Drug Delivery System and its Biomedical Applications
Current Drug Delivery